VPIM
TLX

Vanguard Personalized Indexing Management’s Telix Pharmaceuticals TLX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Buy
33,253
+15,112
+83% +$115K ﹤0.01% 1576
2025
Q4 		$136K Sell
18,141
-237
-1% -$2.28K ﹤0.01% 1780
2025
Q3 		$176K Sell
18,378
-97
-0.5% -$1.19K ﹤0.01% 1732
2025
Q2 		$297K Buy
+18,475
New +$310K ﹤0.01% 1448

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Vanguard Personalized Indexing Management's TLX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Telix Pharmaceuticals (TLX) stake by 83% in Q1 2026, buying an estimated $115K and bringing the position to 33,253 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Vanguard Personalized Indexing Management first reported a position in TLX in Q2 2025 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 33,253 shares of Telix Pharmaceuticals worth $318K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 15,112 Telix Pharmaceuticals shares in Q1 2026, an estimated $115K.
  • Telix Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1576 holding.
  • Vanguard Personalized Indexing Management first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.